Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Short Interest Update

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) was the recipient of a significant decline in short interest during the month of April. As of April 30th, there was short interest totaling 24,551 shares, a decline of 56.7% from the April 15th total of 56,757 shares. Approximately 0.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 29,012 shares, the days-to-cover ratio is currently 0.8 days.

Columbia Research Enhanced Value ETF Stock Down 0.9%

Shares of NYSEARCA REVS traded down $0.29 during midday trading on Friday, reaching $30.76. 22,857 shares of the company were exchanged, compared to its average volume of 62,276. The stock’s 50-day moving average price is $29.49 and its 200-day moving average price is $29.07. The stock has a market cap of $282.99 million, a P/E ratio of 16.41 and a beta of 0.80. Columbia Research Enhanced Value ETF has a one year low of $24.92 and a one year high of $31.18.

Institutional Trading of Columbia Research Enhanced Value ETF

Institutional investors have recently modified their holdings of the business. Steward Partners Investment Advisory LLC bought a new stake in shares of Columbia Research Enhanced Value ETF in the fourth quarter worth $37,000. Cetera Investment Advisers bought a new stake in shares of Columbia Research Enhanced Value ETF in the first quarter worth $300,000. Essex Financial Services Inc. grew its stake in shares of Columbia Research Enhanced Value ETF by 46.1% in the third quarter. Essex Financial Services Inc. now owns 11,811 shares of the company’s stock worth $330,000 after purchasing an additional 3,725 shares during the last quarter. Private Advisor Group LLC bought a new stake in shares of Columbia Research Enhanced Value ETF in the third quarter worth $448,000. Finally, Commonwealth Equity Services LLC grew its stake in shares of Columbia Research Enhanced Value ETF by 14.8% in the fourth quarter. Commonwealth Equity Services LLC now owns 24,788 shares of the company’s stock worth $701,000 after purchasing an additional 3,191 shares during the last quarter.

Columbia Research Enhanced Value ETF Company Profile

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.